GPCR Signaling in Cancer: Advances in Cancer Research, cartea 145
Arun K. Shuklaen Limba Engleză Hardback – 21 feb 2020
G protein-coupled receptors (GPCRs) constitute a large family of cell surface receptors which are involved in nearly every cellular and physiological event. These receptors can recognize a broad array of ligands and they are targeted by nearly one third of the currently prescribed drugs including anti-cancer therapeutics.
- Covers the latest concepts in GPCR signaling and their relevancy to cancer biology
- Presents new indications for anti-cancer therapeutic programs
- Includes sections on cross-talk and signaling networks of GPCRs and effectors in molecular oncology and therapeutics
Din seria Advances in Cancer Research
- Preț: 76.76 lei
- 32% Preț: 685.91 lei
- 32% Preț: 689.02 lei
- 5% Preț: 1197.35 lei
- 32% Preț: 686.61 lei
- 29% Preț: 720.01 lei
- 29% Preț: 719.19 lei
- 29% Preț: 716.88 lei
- 9% Preț: 688.33 lei
- 5% Preț: 718.14 lei
- 5% Preț: 721.81 lei
- 29% Preț: 719.46 lei
- 29% Preț: 722.41 lei
- 29% Preț: 719.39 lei
- 18% Preț: 809.45 lei
- 29% Preț: 723.78 lei
- 36% Preț: 728.74 lei
- 25% Preț: 724.05 lei
- 25% Preț: 723.52 lei
- 19% Preț: 780.84 lei
- 28% Preț: 692.45 lei
- 28% Preț: 690.22 lei
- 25% Preț: 720.30 lei
- 28% Preț: 695.21 lei
- 25% Preț: 721.64 lei
- 25% Preț: 725.05 lei
- 25% Preț: 725.34 lei
- 28% Preț: 688.78 lei
- 28% Preț: 688.78 lei
- 25% Preț: 719.06 lei
Preț: 721.79 lei
Preț vechi: 1018.29 lei
-29% Nou
Puncte Express: 1083
Preț estimativ în valută:
138.14€ • 145.73$ • 115.12£
138.14€ • 145.73$ • 115.12£
Carte tipărită la comandă
Livrare economică 27 decembrie 24 - 10 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128202302
ISBN-10: 0128202300
Pagini: 164
Dimensiuni: 152 x 229 x 10 mm
Greutate: 0.4 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Cancer Research
ISBN-10: 0128202300
Pagini: 164
Dimensiuni: 152 x 229 x 10 mm
Greutate: 0.4 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Cancer Research
Public țintă
Primary researchers and clinicians involved in molecular oncology research and cancer therapeuticsCuprins
1. HERs Transregulation in Cancer Progression: From Discovery to 2020 and Beyond Rakesh Kumar 2. RTKs in Cancer Biology Paul Fisher 3. Advances in EGFR Biochemistry and Biology Yosef Yarden 4. Mouse Models of RTKs/HERs: Lessons and Implications to Biology and Therapy William Joseph Muller 5. MET Receptor in Oncology: From Biomarker to Therapeutic Target Ravi Salgia 6. RTKs in Pathobiology of Head & Neck Cancer Radhakrishna Pillai 7. HER2 or Nuclear HER/RTK in Cancer Mien-Chie Hung 8. FLT3 in Hematopietic Malignancies: From Pathobiology to Therapeutics Premkumar Reddy 9. Advances in IGF1R Biology and –directed Cancer Therapeutics Douglas Yee 10. Advances in Bcr-Abl in Cancer Therapy and Biology Nandini Verma 11. EphRs in Cancer Development and Progression Renata Pasqualini 12. RTK-directed Clinical Advances: Trials and Treatments Masakazu Toi